Hello and welcome to the details of EU preparing case against AstraZeneca over vaccine shortfalls, say sources and now with the details
Subscribe to our Telegram channel for the latest updates on news you need to know.
BRUSSELS, April 22 — The European Commission is working on legal proceedings against AstraZeneca after the drugmaker cut Covid-19 vaccine deliveries to the European Union, according to sources familiar with the matter.
An EU official involved in talks with vaccine makers told Reuters today that a story by Politico on the matter was correct. “EU states have to decide if they (will) participate. It is about fulfilment of deliveries by the end of the second quarter.”
The Anglo-Swedish drugmaker has been under fire in the trading bloc for cutting supplies several times to levels much lower than promised, and potential legal action had been discussed previously.
There was no immediate response from AstraZeneca todat to a request for comment.
Under its contract with the EU, the company had committed to delivering 180 million vaccine doses in the second quarter.
Chief Executive Pascal Soriot told a hearing of the EU parliament in February that he hoped to meet EU expectations on deliveries in that period.
Politico reported the latest possible legal action citing five unnamed European Union diplomats, adding that at a meeting of ambassadors yesterday a majority of EU countries said they would support suing the company. — Reuters
These were the details of the news EU preparing case against AstraZeneca over vaccine shortfalls, say sources for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at Malay Mail and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.